Article Text

Download PDFPDF

Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious irritable bowel syndrome
  1. K-A Gwee1,
  2. S M Collins2,
  3. N W Read3,
  4. A Rajnakova1,
  5. Y Deng2,
  6. J C Graham4,
  7. M W McKendrick4,
  8. S M Moochhala5
  1. 1Department of Medicine, National University Hospital, Singapore
  2. 2Division of Gastroenterology, Intestinal Diseases Research Program, McMaster University, Hamilton, Ontario, Canada
  3. 3Centre for Integrated Medicine, Coleridge House, Northern General Hospital, Sheffield S57AU, UK
  4. 4Department of Infectious Diseases, Royal Hallamshire Hospital, Sheffield S10 2JF, UK
  5. 5Combat Care and Performance Laboratories, Defence Medical Research Institute, DSTA, Singapore
  1. Correspondence to:
    Associate Professor K-A Gwee, Gleneagles Hospital, Annexe Block #05–37, 6A Napier Road, Singapore 258 500;


Background and aims: Chronic bowel disturbances resembling irritable bowel syndrome (IBS) develop in approximately 25% of patients after an episode of infectious diarrhoea. Although we have previously shown that psychosocial factors operating at the time of, or prior to, the acute illness appear to predict the development of post-infectious IBS (PI-IBS), our finding of an increased inflammatory cell number in the rectum persisting for at least three months after the acute infection suggested that there is also an organic component involved in the development of PI-IBS. To evaluate this further, we measured expressions of interleukin 1β (IL-1β) and its receptor antagonist (IL-1ra) in these patients to provide additional evidence that the pathogenesis of PI-IBS is underpinned by an inflammatory process.

Methods: Sequential rectal biopsy samples were prospectively obtained during and three months after acute gastroenteritis, from eight patients who developed post-infectious IBS (INF-IBS) and seven patients who returned to normal bowel habits after acute gastroenteritis (infection controls, INF-CON). Eighteen healthy volunteers who had not suffered from gastroenteritis in the preceding two years served as normal controls (NOR-CON). IL-1β and IL-1ra gene expressions were assayed by reverse transcriptase-polymerase chain reaction, and their levels of expression were quantitated by optical densitometry after electrophoresis on agarose gel.

Results: INF-IBS patients exhibited significantly greater expression of IL-1β mRNA in rectal biopsies than INF-CON patients both during and three months after acute gastroenteritis. Moreover, IL-1β mRNA expression had increased in biopsies taken from INF-IBS patients at three months after the acute infection but no consistent change was observed in INF-CON patients. IL-1β mRNA expression of INF-IBS patients at three months post gastroenteritis was significantly greater than NOR-CON whereas that of INF-CON patients was not significantly different from NOR-CON. Despite these differential changes in IL-1β mRNA expression, no significant changes were observed in IL-1ra mRNA expression among the three groups.

Conclusions: These findings indicate that those patients who develop IBS post infection exhibit greater IL-1β mRNA expression, both during and after the infection, compared with individuals who do not develop PI-IBS. We conclude that such patients may be susceptible to inflammatory stimuli, and that inflammation may play a role in the pathogenesis of PI-IBS.

  • interleukin 1β
  • irritable bowel syndrome
  • post-infectious irritable bowel syndrome
  • IBS, irritable bowel syndrome
  • PI-IBS, post-infectious IBS
  • IL-1β, interleukin 1β
  • IL-1ra, interleukin 1 receptor antagonist
  • PCR, polymerase chain reaction
View Full Text

Statistics from


    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.